Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-10, Stock:PFE, The news for the past five days is as follows:
2018-08-03: nan
2018-08-06: NEWS1: Here's Why Antares Pharma Jumped Today.NEWS2: Here's Why Antares Pharma Jumped Today.NEWS3: Can Mylan Exceed Analysts’ Earnings Estimates in Q2 2018?.NEWS4: Analysts Are Bullish on Gilead Sciences in August.NEWS5: Here&apos;s Why Antares Pharma Jumped Today.NEWS6: Could Mylan Again Report a Sales Decline in Q2 2018?.NEWS7: Alnylam Pharmaceuticals Is &quot;Launch Ready&quot;.NEWS8: Alnylam Pharmaceuticals Is &quot;Launch Ready&quot;.NEWS9: What Analysts Recommend for Mylan before Q2 2018 Earnings.NEWS10: The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis.NEWS11: The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis.NEWS12: Why Pfizer Stock Gained 10% in July.NEWS13: Why Pfizer Stock Gained 10% in July.NEWS14: Why Pfizer Stock Gained 10% in July.NEWS15: The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis.NEWS16: Benzinga Pro's 5 Stocks To Watch Today.NEWS17: Teva Raises Its 2018 Guidance despite Missing Sales Estimate.NEWS18: 10 Hot Stocks to Invest In Right Now.NEWS19: 10 Hot Stocks to Invest In Right Now.NEWS20: Antares Pharma, Pfizer To Develop Drug Device Rescue Pen - Quick Facts.NEWS21: Antares Pharma, Pfizer To Develop Drug Device Rescue Pen - Quick Facts.
2018-08-07: NEWS1: Trump administration opens up more drugs covered by Medicare to price negotiations.NEWS2: Close Update: S&P 500 Perched Near All-Time High on Gains in Energy and Financial Shares.NEWS3: Close Update: S&P 500 Perched Near All-Time High on Gains in Energy and Financial Shares.NEWS4: Mid-Day Update: Wall Street Momentum Lifts S&P 500 Near Record High.NEWS5: Mid-Day Update: Wall Street Momentum Lifts S&P 500 Near Record High.NEWS6: Examining Pfizer’s Performance by Segment in Q2 2018.NEWS7: Q2 Earnings Drive Pharma ETFs Higher.NEWS8: Q2 Earnings Drive Pharma ETFs Higher.NEWS9: Pfizer’s Quarterly Revenue Trend in Q2 2018.NEWS10: Pfizer Reports Revenue Growth in Q2 2018.NEWS11: Q2 Earnings Drive Pharma ETFs Higher.NEWS12: Stock Futures Propped Up by Rally in China, Oil; S&P 500 Within Range of Record High.NEWS13: Stock Futures Propped Up by Rally in China, Oil; S&P 500 Within Range of Record High.NEWS14: Your first trade for Tuesday, August 7.NEWS15: Your first trade for Tuesday, August 7.NEWS16: What Gilead Sciences’ Valuation Trend Indicates.NEWS17: Get Paid While You Wait: 3 Top Dividend Stocks in Healthcare.NEWS18: Get Paid While You Wait: 3 Top Dividend Stocks in Healthcare.NEWS19: Teva’s Granix Gets FDA Approval for Expanded Indication.NEWS20: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS21: Mylan Stock Trending Higher before Its Q2 2018 Results.NEWS22: Get Paid While You Wait: 3 Top Dividend Stocks in Healthcare.NEWS23: CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP Down After-hours.NEWS24: CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP Down After-hours.
2018-08-08: NEWS1: After dismal earnings season, are we witnessing the reven....NEWS2: Protagonist Stock Jumps 58% After Re-Review of Test Results.NEWS3: Protagonist Stock Jumps 58% After Re-Review of Test Results.NEWS4: Mylan N.V. (MYL) Q2 2018 Earnings Conference Call Transcript.NEWS5: 3 Top Dividend Stocks to Buy Right Now.NEWS6: 3 Top Dividend Stocks to Buy Right Now.NEWS7: Eli Lilly Raised Its Non-GAAP Earnings Guidance for Fiscal 2018.NEWS8: 3 Top Dividend Stocks to Buy Right Now.NEWS9: Eli Lilly Raised Its Revenue Guidance for Fiscal 2018.NEWS10: Dow Movers: CAT, HD.NEWS11: Dow Movers: CAT, HD.NEWS12: Protagonist Stock Jumps 58% After Re-Review of Test Results.NEWS13: You Might Still Have Trouble Buying an EpiPen.NEWS14: These Products Saw Falling Sales in Pfizer’s Q2 2018.NEWS15: Eli Lilly: Analysts’ Recommendations in August.NEWS16: Cigna CEO is 'disappointed' Carl Icahn shared his concerns about Express Scripts deal in open letter.NEWS17: Cigna CEO 'disappointed' Carl Icahn shared his concerns about Express Scripts deal in open letter.NEWS18: Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 09, 2018.NEWS19: Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 09, 2018.NEWS20: These Products Contributed to Pfizer’s Growth in Q2 2018.NEWS21: Examining Pfizer’s Performance by Geography in Q2 2018.NEWS22: Why Carl Icahn Is Long Cigna and Short Express Scripts.NEWS23: Why Carl Icahn Is Long Cigna and Short Express Scripts.NEWS24: Trump says will make announcement next week on reducing drug prices.
2018-08-09: NEWS1: ICU Medical, Inc. (ICUI) Q2 2018 Earnings Conference Call Transcript.NEWS2: Sangamo Therapeutics Rose despite Q2 Sales Miss, Higher Losses.NEWS3: Why Sangamo Therapeutics, Inc. Stock Is Popping Today.NEWS4: Why Sangamo Therapeutics, Inc. Stock Is Popping Today.NEWS5: Cabozantinib Expected to Be Exelixis’s Long-Term Growth Driver.NEWS6: Why Sangamo Therapeutics, Inc. Stock Is Popping Today.NEWS7: Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well.NEWS8: Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well.NEWS9: Why Amgen is a Top Socially Responsible Dividend Stock (AMGN).NEWS10: Why Amgen is a Top Socially Responsible Dividend Stock (AMGN).NEWS11: Analysts’ Recommendations for Pfizer on August 6.NEWS12: Aerie (AERI) Earnings Miss in Q2, Rhopressa Performs Well.NEWS13: Examining Pfizer’s Valuation as of August 6.NEWS14: A Look at Recent Developments at Pfizer.

Answer: Decrease